Your browser is no longer supported. Please, upgrade your browser.
MDCO The Medicines Company daily Stock Chart
The Medicines Company
Index- P/E- EPS (ttm)-6.80 Insider Own2.80% Shs Outstand72.45M Perf Week-1.96%
Market Cap2.90B Forward P/E- EPS next Y-1.84 Insider Trans-4.02% Shs Float71.14M Perf Month7.28%
Income-495.00M PEG- EPS next Q-0.60 Inst Own- Short Float27.08% Perf Quarter33.24%
Sales35.10M P/S82.73 EPS this Y-35.50% Inst Trans0.17% Short Ratio23.61 Perf Half Y60.13%
Book/sh0.92 P/B43.57 EPS next Y31.10% ROA- Target Price49.91 Perf Year6.54%
Cash/sh3.32 P/C12.07 EPS next 5Y- ROE- 52W Range24.45 - 43.79 Perf YTD46.60%
Dividend- P/FCF- EPS past 5Y-55.80% ROI-65.60% 52W High-9.18% Beta0.74
Dividend %- Quick Ratio2.50 Sales past 5Y-39.60% Gross Margin-13.80% 52W Low62.66% ATR1.51
Employees170 Current Ratio2.60 Sales Q/Q-55.40% Oper. Margin- RSI (14)63.38 Volatility3.88% 4.39%
OptionableYes Debt/Eq0.00 EPS Q/Q-15.10% Profit Margin- Rel Volume0.40 Prev Close40.08
ShortableYes LT Debt/Eq9.69 EarningsAug 08 BMO Payout- Avg Volume815.92K Price39.77
Recom1.50 SMA204.82% SMA5012.13% SMA20024.36% Volume317,307 Change-0.77%
Jun-07-18Initiated B. Riley FBR, Inc. Buy $55
Jan-24-18Resumed JP Morgan Overweight $45
Oct-24-17Initiated Guggenheim Buy $45
Aug-29-17Reiterated Chardan Capital Markets Buy $80 → $85
Dec-05-16Initiated H.C. Wainwright Buy $57
Nov-16-16Reiterated RBC Capital Mkts Outperform $45 → $52
Nov-08-16Reiterated RBC Capital Mkts Outperform $48 → $45
Mar-21-16Reiterated Chardan Capital Markets Buy $50 → $65
Nov-16-15Reiterated RBC Capital Mkts Outperform $46 → $48
Nov-04-15Initiated Chardan Capital Markets Buy $50
Aug-31-15Reiterated RBC Capital Mkts Outperform $39 → $46
Aug-28-15Upgrade Jefferies Hold → Buy
Jul-06-15Upgrade Mizuho Neutral → Buy $28 → $41
Apr-10-15Reiterated Mizuho Neutral $30 → $27.50
Mar-20-15Initiated Mizuho Neutral $30
Feb-13-14Reiterated RBC Capital Mkts Outperform $50 → $44
Dec-05-13Reiterated RBC Capital Mkts Outperform $41 → $50
Jun-21-13Resumed Oppenheimer Perform
Feb-21-13Reiterated WallachBeth Buy $30 → $38
Feb-05-13Reiterated RBC Capital Mkts Outperform $34 → $37
Jul-20-18 06:00AM  5 Favorite Biotech Bets Investopedia
Jul-19-18 08:48AM  Delivering Alpha 2018: Everything You Need To Know Benzinga
Jul-18-18 03:18PM  Alex Denner adds Ironwood Pharma and Medicines Co. to bes... CNBC Videos
Jul-13-18 12:01AM  [$$] High-profile health app under scrutiny after doctors complaints Financial Times
Jul-11-18 05:08AM  [$$] Supply of 100 UK medicines to be disrupted, warns EMA Financial Times
Jul-02-18 07:25AM  Complimentary Technical Snapshots on Mylan and Three More Generic Drugs Stocks ACCESSWIRE
Jun-28-18 05:31PM  Medicines Company's Inclisiran Studies to Continue Unmodified Zacks
Jun-27-18 07:00AM  The Medicines Company Announces Recommendation by Independent Data Monitoring Committee to Continue Inclisiran Phase III Trials Following Review of Unblinded Data Business Wire
Jun-26-18 07:00AM  New Data Presented at the American Diabetes Association 78th Scientific Sessions® Reinforce the Potential of The Medicines Companys inclisiran in Patients with Diabetes Business Wire
Jun-11-18 04:49PM  Alnylam Reports Positive Data on Lumasiran in Renal Disease Zacks
Jun-07-18 08:50PM  What Does The Medicines Companys (NASDAQ:MDCO) Share Price Indicate? Simply Wall St.
May-29-18 08:30AM  Today's Research Reports on Trending Tickers: Horizon Pharma and The Medicines Company ACCESSWIRE
May-25-18 09:11AM  Medicines Company (MDCO) Up 11.4% Since Earnings Report: Can It Continue? Zacks
May-24-18 07:15AM  Free Daily Technical Summary Reports on Mylan and Three Other Generic Drugs Stocks ACCESSWIRE
May-07-18 10:45AM  The Medicines Company Announces Inclisiran Data Showing Significant Reductions in Potentially Harmful Subtypes of Bad Cholesterol (Atherogenic Lipoproteins) Linked to Heart Attack and Stroke Business Wire
May-03-18 07:50AM  Blog Exposure - Ironwood to Separate Its Soluble Guanylate Cyclase Business from Commercial and Gastrointestinal Business ACCESSWIRE
Apr-30-18 07:00AM  The Medicines Company Presents New Data at the National Lipid Association Scientific Sessions Business Wire
Apr-27-18 12:19PM  Medicines Company's (MDCO) Q1 Loss Widens, Revenues Tank Y/Y Zacks
Apr-26-18 12:15AM  Edited Transcript of MDCO earnings conference call or presentation 25-Apr-18 12:30pm GMT Thomson Reuters StreetEvents +5.56%
Apr-25-18 11:31PM  [$$] UK ratifies European patent court agreement Financial Times
07:16AM  Medicines Co.: 1Q Earnings Snapshot Associated Press
07:00AM  The Medicines Company Reports First-Quarter 2018 Results Business Wire
06:30AM  [$$] Some treatments for depression and bladder linked to dementia Financial Times
06:30AM  Medicines Company to Host Earnings Call ACCESSWIRE
Apr-19-18 07:00AM  The Medicines Company to Announce First-Quarter 2018 Financial Results on April 25 Business Wire
Apr-09-18 04:50PM  Biotech activist Alex Denners next target: Ironwood Pharma CNBC
Apr-04-18 10:00PM  [$$] Babylon signs Tencent deal to deploy health technology on WeChat Financial Times
Mar-27-18 08:05PM  The Medicines Company Announces Chief Financial Officer Transition Business Wire
Mar-26-18 08:43AM  [$$] Business school: book prize, engineering talent, cost of an MBA Financial Times
Mar-24-18 10:00PM  [$$] How to manage a Brexit-enforced move Financial Times
Mar-23-18 09:52AM  The Medicines Company (MDCO) Up 4.8% Since Earnings Report: Can It Continue? Zacks
08:56AM  [$$] FT Health: Time for action on tuberculosis Financial Times
Mar-20-18 08:12AM  The Medicines Company CEO, Dr. Clive Meanwell, On The Impact Of ODYSSEY OUTCOMES For Heart Patients Forbes
Mar-16-18 07:00AM  The Medicines Company to Participate in the Oppenheimer 28th Annual Healthcare Conference Business Wire
Mar-13-18 10:06PM  [$$] Brexit and the NHS dividend Financial Times
Mar-12-18 04:53PM  How A Strong Trial From Regeneron Pharma Could Help These Rivals Investor's Business Daily
08:37AM  In Cholesterol Drug Battle, Sanofi/Regeneron Jolt Prospects Of The Medicines Company And Esperion Forbes
05:40AM  Alnylam Pharmaceuticals (ALNY) Up 1.6% Since Earnings Report: Can It Continue? Zacks
Mar-08-18 04:30PM  The Medicines Company Reaches Enrollment Target for ORION-10 Ahead of Schedule Business Wire
07:00AM  The Medicines Company to Participate in the Cowen 38th Annual Health Care Conference Business Wire
Mar-07-18 06:06AM  [$$] EU rejects UKs plans for post-Brexit trade relationship Financial Times
Mar-05-18 08:26PM  [$$] Can Britain stick with the EU regulators? Financial Times
Mar-01-18 03:25PM  Four Stocks Move Thursday +8.65%
01:53PM  Medicines Company cuts board size, activist Denner to get more control Reuters
11:31AM  Medicines Co. shares surge 6.2% on board restructuring, activist investor's role MarketWatch
11:10AM  Activist Alex Denner to gain board control at Medicines Company CNBC
Feb-27-18 11:00PM  [$$] Brexit risks for UK rare disease sufferers must be addressed Financial Times
07:00AM  The Medicines Company Appoints Dr. Sarah Schlesinger to Its Board of Directors Business Wire
Feb-22-18 10:24AM  Medicines Company (MDCO) Reports Q4 Loss, Revenues Slump Y/Y Zacks -5.66%
06:00AM  A Six-Pack of Biotech Bets Investopedia
Feb-21-18 07:21AM  Medicines Co. reports 4Q loss Associated Press
07:00AM  The Medicines Company Reports Fourth-Quarter and Full-Year 2017 Business and Financial Results Business Wire
06:30AM  Medicines Company to Host Earnings Call ACCESSWIRE
Feb-20-18 07:00AM  The Medicines Company Reaches Enrollment Target for ORION-9 Ahead of Schedule Business Wire
Feb-15-18 08:25AM  Investor Expectations to Drive Momentum within Workday, The Medicines, Celldex Therapeutics, Lannett, Oclaro, and Antares Pharma Discovering Underlying Factors of Influence GlobeNewswire
Feb-14-18 04:15PM  The Medicines Company to Host Conference Call and Webcast Discussing Fourth-Quarter and Full-Year 2017 Financial Results Business Wire
Feb-12-18 03:37PM  Alnylam Pharmaceuticals Starts the Wait for Approval Motley Fool
Feb-09-18 09:54AM  Alnylam's (ALNY) Q4 Earnings and Revenues Top Estimates Zacks
Feb-08-18 04:15PM  The Medicines Company to Participate in the Leerink Partners 7th Annual Global Healthcare Conference Business Wire -5.96%
Feb-07-18 07:09AM  What Bargain Hunting? Bet on 6 Stocks With Rising P/E Zacks
Feb-06-18 09:04AM  3 Top Cholesterol Drug Stocks to Consider Buying Now Motley Fool
Jan-27-18 10:32AM  3 Biotech Stocks That Soared This Week: Are They Buys? Motley Fool
Jan-25-18 08:16AM  CORRECTING and REPLACING Inclisirans First Pivotal Trial Achieves Target Enrollment Ahead of Schedule Business Wire
Jan-24-18 04:41PM  Why The Medicinces Company Is Having an Outstanding Week Motley Fool +6.04%
Jan-22-18 09:58AM  Citi Downgrades Esperion As Hope Of Acquisition Dwindles Benzinga +16.03%
Jan-11-18 08:40AM  Is the Options Market Predicting a Spike in Medicines Company (MDCO) Stock? Zacks
Jan-10-18 07:20AM  Blog Exposure - The Medicines Co. Completes Divestiture of Infectious Disease Business Unit to Melinta Therapeutics ACCESSWIRE
Jan-09-18 07:45AM  Mallinckrodt (MNK) to Sell Recothrom and Preveleak to Baxter Zacks
Jan-08-18 08:49AM  The Zacks Analyst Blog Highlights: XOMA, Exelixis, Emergent BioSolutions and Medicines Zacks
07:00AM  The Medicines Company Announces Closing of Divestiture of Infectious Disease Business Unit to Melinta Therapeutics Business Wire
07:00AM  Melinta Therapeutics Completes Acquisition of The Medicines Companys Infectious Disease Portfolio GlobeNewswire
Jan-05-18 04:25PM  4 Biotech Stocks to Watch in the New Year Zacks
Jan-03-18 04:30PM  The Medicines Company to Present at the 36th Annual J. P. Morgan Healthcare Conference Business Wire
Jan-02-18 08:07AM  See what the IHS Markit Score report has to say about Medicines Co. Markit
Dec-21-17 08:40AM  Is the Options Market Predicting a Spike in The Medicines Company (MDCO) Stock? Zacks +6.07%
Dec-13-17 07:00AM  The Medicines Company to Host Investor Day on January 23, 2018 Business Wire
Dec-12-17 01:36PM  ETFs with exposure to The Medicines Co. : December 12, 2017 Capital Cube
Dec-08-17 08:06AM  See what the IHS Markit Score report has to say about Medicines Co. Markit
Dec-04-17 01:00PM  [$$] Icahn Protege's Big Biotech Buys: Biogen, Medicines
Dec-01-17 08:30AM  Report: Exploring Fundamental Drivers Behind Lannett, Oclaro, Antares Pharma, Workday, The Medicines, and Celldex Therapeutics New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
07:30AM  Blog Exposure - Melinta Therapeutics to Acquire Infectious Disease Business from The Medicines Co. ACCESSWIRE
Nov-30-17 04:55PM  Medicines Company to Sell Infectious Disease Unit to Melinta Zacks
12:59PM  Oppenheimer Raises Its Prognosis For The Medicines Company Benzinga
09:25AM  Melinta Up After Deal for Medicines' Infectious Disease Unit -- Biotech Movers
Nov-29-17 04:59PM  Here's How Alnylam Pharmaceuticals, Inc. Crushed It in 2017 Motley Fool
04:38PM  Why Medicines Co. Is Tumbling Despite $270 Million Deal Investor's Business Daily
09:47AM  The Medicines Company (MDCO): Time For A Financial Health Check Simply Wall St.
07:41AM  UPDATE: Medicines Co. agrees to sell infectious disease unit to Melinta Therapeutics MarketWatch
07:12AM  Deerfield Supports Melinta Therapeutics Acquisition of The Medicines Company's Infectious Disease Business with a $240 million Commitment to Melinta and a $100 million Commitment to The Medicines Company PR Newswire
07:00AM  The Medicines Company Announces Definitive Agreement to Sell its Infectious Disease Business Unit to Melinta Therapeutics Business Wire
07:00AM  Melinta Therapeutics Enters Into Agreement to Acquire Infectious Disease Business from The Medicines Company GlobeNewswire
Nov-27-17 08:07AM  See what the IHS Markit Score report has to say about Medicines Co. Markit
Nov-24-17 10:45AM  ETFs with exposure to The Medicines Co. : November 24, 2017 Capital Cube
Nov-23-17 08:06AM  See what the IHS Markit Score report has to say about Medicines Co. Markit
Nov-21-17 07:00AM  Earnings Review and Free Research Report: The Medicines Reported Better Than Expected Earnings Results ACCESSWIRE
Nov-15-17 07:30AM  The Medicines Company Names Dr. Fred Eshelman as Executive Chairman; Appoints Geno Germano to Its Board of Directors Business Wire
Nov-13-17 12:45PM  ETFs with exposure to The Medicines Co. : November 13, 2017 Capital Cube
Nov-10-17 09:58AM  The Medicines Co. :MDCO-US: Earnings Analysis: Q3, 2017 By the Numbers : November 10, 2017 Capital Cube
08:06AM  See what the IHS Markit Score report has to say about Medicines Co. Markit
Nov-09-17 07:35AM  The Medicines Company's PCSK9 Inhibitor Strategy: More Heart Patients Via Lower Pricing Forbes
The Medicines Company, a biopharmaceutical company, provides medicines to treat acute and intensive care patients. The company markets Angiomax, an intravenous direct thrombin inhibitor used as an anticoagulant in combination with aspirin in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty, and for patients undergoing percutaneous coronary intervention in the United States. It primarily focuses on developing Inclisiran, a lipid-lowering drug to reduce LDL-cholesterol (LDL-C) in patients with atherosclerotic cardiovascular disease or cardiovascular risk-equivalents. The company has collaboration agreements with Alnylam Pharmaceuticals, Inc.; SciClone Pharmaceuticals; and Symbio Pharmaceuticals Limited. The Medicines Company was founded in 1996 and is based in Parsippany, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MEANWELL CLIVECEOJul 02Sale36.0750,0001,803,500402,034Jul 05 04:53 PM
Spigelman Melvin KDirectorMay 25Option Exercise18.307,500137,25060,633May 29 05:03 PM
Spigelman Melvin KDirectorMay 25Sale32.207,500241,50053,133May 29 05:03 PM
KESSLER ARMIN MDirectorMay 10Option Exercise18.307,500137,250138,493May 14 05:07 PM
KESSLER ARMIN MDirectorApr 16Sale30.0510,000300,500130,993Apr 18 05:51 PM
WYATT ELIZABETH H SDirectorMar 22Option Exercise18.307,500137,25060,633Mar 23 04:39 PM
CROUSE WILLIAMDirectorMar 21Option Exercise18.307,500137,25060,633Mar 23 04:39 PM
CROUSE WILLIAMDirectorMar 21Sale32.267,500241,95053,133Mar 23 04:39 PM
KESSLER ARMIN MDirectorJan 16Sale27.3710,000273,700140,993Apr 18 05:51 PM
MEANWELL CLIVECEODec 15Option Exercise19.36200,9203,889,811587,652Dec 19 07:07 PM
MEANWELL CLIVECEODec 15Sale27.24136,2503,711,450451,402Dec 19 07:07 PM
ESHELMAN FREDRIC NExecutive ChairmanDec 08Buy26.65100,0002,665,0001,128,383Dec 11 06:23 PM
ESHELMAN FREDRIC NExecutive ChairmanDec 07Buy26.46100,0002,646,0001,028,383Dec 11 06:23 PM
Panayiotopoulos ParisDirectorNov 30Buy30.973,21599,5696,452Dec 01 05:47 PM
DENNER ALEXANDER JDirectorNov 29Buy30.03170,0005,105,1001,922,000Nov 30 07:30 AM
HUGIN ROBERT JDirectorNov 09Option Exercise15.7247,798751,228163,431Nov 13 06:18 PM